Product analysis
Ginkgo Smart combines ginkgo with other ingredients for attention and memory support, though ginkgo findings are mixed. Unclear ginkgo preparation details limit how confidently those benefits apply.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
Most ingredient forms are unspecified, including the omega-3 form. Several named forms are present, but they do not establish the quality of the complete combination.
Ingredient Transparency65
Most amounts are listed, but few ingredient forms are identified. Some composition details are clear, while one part of the formula remains uncertain.
Value For Money28
The cost is unfavorable when judged by the amount of deanol. Value for the other ingredients remains uncertain, including omega-3 without a usable EPA and DHA comparison.
Customer Satisfaction83
Customer ratings are generally very positive. A substantial number of ratings gives a broad view of customer satisfaction.
Product Focus41
Ginkgo provides the main link to attention and memory, with mixed evidence. Small supporting amounts offer limited grounds for expecting a noticeable boost in everyday productivity.
- Format
Softgel - Container
- 60 Liquid(s)
- Per serving
- $0.49
- Also available
Ginkgo Smart$34.94- Customer rating
- 4.6 · 2,381 ratings
Goals
Ginkgo at 520 mg provides the main reviewed connection to brain energy processes. The 25 mg acetyl L-carnitine adds little at this amount, and the fish-oil total does not provide a declared DHA amount for evaluating neuronal membrane support.
How this product is rated for Brain Health
Ingredient fit62
Goal fit
Dose adequacy
Pathways43
Depth
Breadth
Evidence58
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ginkgo is the main cognitive-related ingredient, with preliminary attention-speed relevance that depends on the extract. The 520 mg declaration does not confirm the preparation used in the reviewed work.
The small choline, DMAE and acetyl L-carnitine amounts offer limited grounds for an added effect. Fish oil at 600 mg does not establish a DHA amount, and huperzine-source material adds no reliable general cognitive benefit.
How this product is rated for Cognitive Support
Ingredient fit68
Goal fit
Dose adequacy
Pathways40
Depth
Breadth
Evidence25
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ginkgo is the main connection to memory and attention, although cognitive findings are mixed. Its 520 mg amount earns no extra support over the saved reference range.
The declared 180 mg omega-3 amount is small against the saved comparison reference, and evidence does not support a dependable increase in everyday work output.
How this product is rated for Productivity Boost
Ingredient fit60
Goal fit
Dose adequacy
Pathways13
Depth
Breadth
Evidence53
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ginkgo is the main focus-related botanical, with mixed evidence for attention. The 30 mg choline and 25 mg acetyl L-carnitine amounts make smaller supporting contributions through neurotransmitter and cellular-energy roles, without clear evidence of an immediate concentration boost.
How this product is rated for Mental Focus
Ingredient fit60
Goal fit
Dose adequacy
Pathways44
Depth
Breadth
Evidence62
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 15 Calorie(s) | |
Total Fat | 1 Gram(s) | |
Cholesterol | 5 mg | |
Protein | 1 Gram(s) | |
Choline (Choline Bitartrate) | 30 mg | |
Fish Oil | 600 mg | |
Omega-3 Fatty Acids | 180 mg | |
Ginkgo, Powder (Ginkgo biloba, Powder) | 400 mg | |
Ginkgo Leaf Extract | 120 mg | |
Flavone Glycosides | 28.8 mg | |
Terpene Lactones | 7.2 mg | |
Dimethylaminoethanol Bitartrate | 40 mg | |
Trimethylglycine Hydrochloride | 40 mg | |
Acetyl-L-Carnitine (Acetyl-L-Carnitine Hydrochloride) | 25 mg | |
Alpha-Lipoic Acid | 15 mg | |
Velvet Bean seed extract | 10 mg | |
Toothed Clubmoss Leaf Extract | 1 mg | |
BioPerine Complex | 6 mg | |
BioPerine (Black Pepper Fruit Extract) | 0 NP | |
Ginger Rhizome Extract (Gingerols) | 0 NP |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Deanol Form Specificity
Active Deanol Yield Transparency
Dose, Safety & Label Transparency78
Dosage Appropriateness
Specific Safety Warnings
Value10
Price Per 100mg Active Deanol
How this ingredient is rated
Active Ingredient Quality & Bioavailability53
Choline Form Efficacy & Bioavailability
Formula Purity & Excipient Quality
Dose, Safety & Label Transparency47
Choline Dose by Declared Basis
Elemental Yield Transparency
Value20
Price per 100 mg of Declared Choline Basis
How this ingredient is rated
Composition and Label Disclosure16
Marker and Preparation Disclosure
Declared Ginkgolic Acid Limit
Composition and Label Disclosure100
Individual Preparation Amount Disclosure
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
- Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study.
- Choline intake during pregnancy and child cognition at age 7 years.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes.
- Senile dementia: treatment with deanol.
- Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.